Akèy › Ipèsansibilite arachid › Kalifòni
Etid klinik pou Ipèsansibilite arachid nan Kalifòni
4 etid pou Ipèsansibilite arachid ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- California Allergy and Asthma Medical Group, Los Angeles
Ap rekriteFaz 3
Laj 12 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- University of California, Los Angeles: Department of Medicine, Division of Clinical Immunology and Allergy, Los Angeles
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- Stanford School of Medicine: Sean N. Parker Center for Allergy & Asthma Research, Palo Alto
Ap rekriteEtid obsèvasyon
12 Months – 17 Years · Tout sèks · Mizajou Sep 9, 2026 · NCT07279467Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Sean N. Parker Center for Allergy and Asthma Research, Palo Alto
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Jul 28, 2026 · NCT07220811Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.